Market Tracker

02/10 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

21.98
Delayed Data
As of Feb 10
 +0.63 / +2.95%
Today’s Change
20.07
Today|||52-Week Range
42.48
-22.30%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close21.35
Today’s open21.50
Day’s range21.27 - 22.64
Volume378,267
Average volume (3 months)377,824
Market cap$703.4M
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+36.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio85.2
Price/Sales10.36
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.19+1.04%
CLVSClovis Oncology Inc+0.42+2.26%
FWPForward Pharma A/S+0.99+6.63%
ZIOPZIOPHARM Oncology In...-0.08-1.47%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts